NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 54 filers reported holding NEXTCURE INC in Q3 2022. The put-call ratio across all filers is 3.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,957 | -28.3% | 10,044 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $18,079 | +21.6% | 10,044 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $14,865 | +5.0% | 10,044 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $14,162 | -49.4% | 10,044 | 0.0% | 0.01% | -44.4% |
| Q3 2022 | $28,000 | -40.4% | 10,044 | 0.0% | 0.01% | -40.0% |
| Q2 2022 | $47,000 | -4.1% | 10,044 | 0.0% | 0.02% | +50.0% |
| Q1 2022 | $49,000 | -18.3% | 10,044 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $60,000 | -11.8% | 10,044 | 0.0% | 0.01% | +33.3% |
| Q3 2021 | $68,000 | -16.0% | 10,044 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $81,000 | -19.8% | 10,044 | 0.0% | 0.01% | -42.9% |
| Q1 2021 | $101,000 | -7.3% | 10,044 | 0.0% | 0.01% | -67.4% |
| Q4 2020 | $109,000 | +23.9% | 10,044 | 0.0% | 0.04% | +30.3% |
| Q3 2020 | $88,000 | -59.1% | 10,044 | 0.0% | 0.03% | -64.5% |
| Q2 2020 | $215,000 | -42.2% | 10,044 | 0.0% | 0.09% | -48.3% |
| Q1 2020 | $372,000 | – | 10,044 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |